Skip to main content
. 2019 Sep 24;9:13744. doi: 10.1038/s41598-019-50207-y

Figure 5.

Figure 5

Effect of DD on growth and metabolism of MRSA at BIC (225 µg/mL). (a) Growth curve analysis. (b) CFU/mL of control, rifampicin and DD treated MRSA exhibiting non-antibacterial nature of DD at 225 µg/mL concentration. (c) DD treated MRSA cells were metabolically viable as comparable with control cells which was confirmed by alamar blue assay. Error bars indicate standard deviations.